310 related articles for article (PubMed ID: 29666156)
1. Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.
Szeto CC; McIntyre CW; Li PK
J Am Soc Nephrol; 2018 Jun; 29(6):1601-1608. PubMed ID: 29666156
[TBL] [Abstract][Full Text] [Related]
2. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
[TBL] [Abstract][Full Text] [Related]
3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
4. Microbiome and Cardiovascular Disease in CKD.
Jovanovich A; Isakova T; Stubbs J
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
Andersen K; Kesper MS; Marschner JA; Konrad L; Ryu M; Kumar Vr S; Kulkarni OP; Mulay SR; Romoli S; Demleitner J; Schiller P; Dietrich A; Müller S; Gross O; Ruscheweyh HJ; Huson DH; Stecher B; Anders HJ
J Am Soc Nephrol; 2017 Jan; 28(1):76-83. PubMed ID: 27151924
[TBL] [Abstract][Full Text] [Related]
6. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
[TBL] [Abstract][Full Text] [Related]
7. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
8. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
Vaziri ND; Zhao YY; Pahl MV
Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
[TBL] [Abstract][Full Text] [Related]
9. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
[TBL] [Abstract][Full Text] [Related]
10. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
Lau WL; Vaziri ND
J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes.
Filiopoulos V; Vlassopoulos D
Inflamm Allergy Drug Targets; 2009 Dec; 8(5):369-82. PubMed ID: 20025585
[TBL] [Abstract][Full Text] [Related]
12. Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease.
Song JY; Shen TC; Hou YC; Chang JF; Lu CL; Liu WC; Chen PJ; Chen BH; Zheng CM; Lu KC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878067
[TBL] [Abstract][Full Text] [Related]
13. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
14. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet.
Ikee R; Sasaki N; Yasuda T; Fukazawa S
Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255763
[TBL] [Abstract][Full Text] [Related]
15. [Uremic toxins and gut micro biome].
Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
[TBL] [Abstract][Full Text] [Related]
16. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].
Mikhailova NA
Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
18. Alterations of intestinal barrier and microbiota in chronic kidney disease.
Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600
[TBL] [Abstract][Full Text] [Related]
19. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD.
Briskey D; Tucker PS; Johnson DW; Coombes JS
Nitric Oxide; 2016 Jul; 57():64-70. PubMed ID: 27164294
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
